Active	Status	Sponsor type	Region	Phase	Filter
6 Active 10 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Campbell, Thomas B
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26
STOMP, NCT05534984: Study of Tecovirimat for Human Mpox Virus	Active, not recruiting	3	719	Japan, US, RoW	Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label)	National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies	MPOX	10/24	09/25
PURGE-C, NCT04042740: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection	Completed	2	45	US, RoW	Glecaprevir/Pibrentasvir (G/P), Mavyret	Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, AbbVie, National Institute of Allergy and Infectious Diseases (NIAID)	Hepatitis C Infection, HIV Infection	05/23	08/23
Borok, Margaret
No trials found